Platelet-derived growth factor: A potentially important cytokine in glomerular disease
Kidney International, ISSN: 0085-2538, Vol: 41, Issue: 3, Page: 590-594
1992
- 61Citations
- 1Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations61
- Citation Indexes61
- 61
- CrossRef37
- Captures1
- Readers1
Article Description
Many glomerular diseases, including IgA nephropathy, membranoproliferative glomerulonephritis (GN), variants of idiopathic focal sclerosis, and lupus nephritis are characterized by mesangial cell proliferation. There is increasing evidence that mesangial cell proliferation in GN may not be a benign process, but may be associated with activation of the mesangial cell, as reflected by the acquisition of a smooth muscle cell-like pheno-type [1] and by the synthesis and secretion of increased amounts of normal and abnormal mesangial matrix components [2] and proteinases (David Lovett, manuscript submitted). Thus, an understanding of the mechanisms that initiate and maintain the proliferative response in active GN may provide useful insights into future therapeutic strategies of these diseases.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0085253815575285; http://dx.doi.org/10.1038/ki.1992.88; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0026538075&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/1573833; https://linkinghub.elsevier.com/retrieve/pii/S0085253815575285; https://dx.doi.org/10.1038/ki.1992.88
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know